Abbott Surges After Avoiding Another 'Eye-Popping' Verdict In Baby Formula Trial

Abbott Surges After Avoiding Another 'Eye-Popping' Verdict In Baby Formula Trial · Investor's Business Daily
ALLISON GATLIN
3 min read

In This Article:

Abbott stock surged early Friday after a jury decided baby formula from Abbott and Mead Johnson are not responsible for a boy's disease.

Recommended Stories